GYN | The URGE Trial

Study Brief | The purpose of this research study is to determine genes that affect how a person’s body metabolizes a drug can help us predict how women will respond to a FDA approved medication (fesoterodine fumarate) for urgency urinary incontinence (UUI).

Name: URGE: Understanding the Response of Fesoterodine through Genetic Evaluation in the Elderly

 Principal Investigator: Dr. Jennifer Wu

Recruitment Length: October 2014

Participation Details: Participation will include a baseline visit, followed by three additional follow up visits. The total length of the study could take 6-8 weeks, depending on how much time occurs between the baseline visit and Week 0 visit.

Compensation Available: Participants will receive free medication for 4 weeks. They will also be reimbursed up to $80 in gift cards for taking part in this study.

Qualifiers for the study:

  • Women ≥ 65 years
  • ≥ 3 urge urinary incontinence episodes on a 3-day voiding diary
  • Interested in trying medication for urge incontinence 

Online Interest Form
Study Coordinator: 919-843-8259


IRB Approval Number: 13-2066

Filed under: ,